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Breast cancer is the leading cause of cancer death in women in the United States; it is estimated that approximately 180,000 new cases will be diagnosed during 2008 [1]. Breast cancer cells, as most cancer cells, have a high level of glucose uptake and metabolism compared with normal cells [2-4]. Increased glucose uptake by cancer cells is mediated through increased expression of facilitative glucose transporters (GLUTs)
 [2, 3, 5, 6] 
. Fourteen members of the mammalian facilitative GLUT family have been identified: GLUT1-12, GLUT14, and the Hϩ/myoinositol transporter (HMIT). GLUT1 was believed to be the isoform of the facilitative GLUTs expressed ubiquitously in normal tissues, and overexpressed in human cancers
. However, an analysis of 154 human neoplasms failed to detect GLUT1 in 87 cancers [9] . A study of 118 breast cancers observed expression of GLUT1 in only 42% of the samples [10] . The lack of GLUT1 expression in a significant fraction of cancers suggested that cancers may express other GLUT isoforms [7, 11] . To address this hypothesis, we evaluated 215 different cancers for expression of GLUT1-6 and GLUT9 and confirmed GLUT1 as the most widely expressed isoform in human cancers, with 58% of the samples showing moderate to high levels of immunostaining for GLUT1 [5] . This [12] [13] [14] [15] . In addition to expression of GLUT1, human cancers also expressed the GLUT isoforms GLUT2 (31%) and GLUT5 (27%) [5] , which [5] , suggested that, in addition to glucose, fructose may have an important role in maintaining cancer cell metabolism and that fructose uptake also could be used for PET imaging [5, 16] . Even though expression of the facilitative GLUTs in breast cancer have been studied in some detail [5, 10, 17, 18] , little is known about the biological contribution of GLUT1 to malignant potential in breast cancer. High level of expression of GLUT1 was correlated with increased aggressiveness and poor prognosis in lung cancer [19] [20] [21] and liver vascular tumours [22] . Moreover, GLUT1 overexpression correlated with lymph node metastases and poor prognosis in colorectal cancer [23, 24] , and malignant progression in Barrett's oesophagus [25] .
cellular property has been utilized extensively in positron emission tomography (PET) for noninvasive detection and evaluation of therapeutic response in a wide variety of cancers using the glucose analogue 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) as a radiotracer
Nutritional channels in breast cancer
Although breast cancers overexpress GLUT1, considerable variability in the level of expression of GLUT1 was observed between different samples [5] . This (Fig. 2D-F , arrows and inset), others did not ( Fig. 2A-C, inset) . However, all cells that showed expression of the proliferation marker PCNA also showed increased expression of GLUT1 in SBRII cancers (Fig. 2D-F and inset) . (Figs. 3 and 4) . The level of intensity of the GLUT1 immunostaining was elevated in breast cancer cells compared with the surrounding stroma (Fig. 3A ). GLUT1 showed a heterogeneous level of expression within cancer parenchymal cells. Higher levels of GLUT1 immunoreaction were observed at the centre of the tumour mass, where cellular density was increased (Fig. 3A-E preferentially to the areas of the cellular membrane that seemed to be involved in cell-to-cell contact (Fig. 3A, arrows) . In contrast, GLUT1 immunostaining was observed at lower intensity at portions of the cellular membrane in contact with the surrounding stroma (Fig. 3A, arrow head) . Immunofluorescence coupled to digital image analyses were utilized to obtain a semi-quantitative appreciation of the level of intensity of GLUT1 immunostaining at the tissue and cellular level in three different patients (Fig. 3B-E) . These studies confirmed heterogeneous expression of GLUT1 within the breast cancer parenchyma (Fig. 3B-E) , with the highest levels of expression of GLUT1 localized to the areas of the cellular membranes involved in cell-to-cell contact ( Fig. 3D and E,  arrows) . In contrast, levels of expression of GLUT1 were lowto-negative in the areas of the cellular membranes that contacted surrounding stroma (Fig. 3D and E, arrow heads) .
Results
GLUT1 expression in human breast cancer tissues with differing malignant potential
Even though there seems to be a preferential localization of GLUT1 to the portion of the cellular membrane involved in cellto-cell contact in SBRII breast cancer, spaces were detected between these membranes. This suggests the presence of cavities between cancer cells at these specific areas (Fig. 3C-E) . (Fig. 4A-C, black arrow) , and GLUT1 expression was decreased in apical areas of cellular membranes exposed to the surrounding stroma (Fig. 4A-D,  arrow) . In the ultrastructural analyses, GLUT1 immunostaining localized mostly at cellular membranes that formed 'canaliculilike structures' (Fig. 4A, asterisks, B, C, (Fig. 4B, arrow heads) . (Fig. 5C, arrow) . (Fig. 5F, I, arrows) . In addition, low levels of GLUT1 immunostaining were observed with a pattern of cytoplasmic localization (Fig. 5D, F (Fig. 6) . Histological analysis of these xenografts indicated rapid growth; cells showed a characteristic pattern of cellular columns with active proliferation (Fig. 6A, B, asterisks) , and areas of cell death due to necrosis and apoptosis (Fig. 6A, arrows) , that was detected using TUNEL technique (Fig. 6B, arrow) . GLUT1 expression was heterogeneous within the xenograft tissue (Fig. 6C) and was associated with areas of active proliferation and increased cellular density (Fig. 6C, 
Based upon this observation, immunocytochemistry coupled to transmission electron microscopy (TEM) was utilized to characterize further the putative biological role of GLUT1 at the sites of preferential localization. TEM studies were performed using 60 nm tissue sections of histological grade SBRII breast cancers (Fig. 4). Ultrastructural analyses confirmed the results obtained from standard immunohistochemistry and immunofluorescence analyses. GLUT1 localized to areas of the cellular membranes that faced neighbouring cells
arrows). However, GLUT1 immunostaining was not detected in areas of cellular membranes that faced neighbouring cells but did not form the canaliculi-like structures
The MDA-MB-468 cell line grown as xenografts in nude athymic BALB/c male mice mimic the preferential localization of GLUT1 observed in histological grade SBRII breast cancer
GLUT1 subcellular distribution was analysed in vitro using immunocytochemistry in the normal epithelial breast cell line, HMEC, and in two-breast cancer cell lines, the hormone-sensitive MCF-7, and the hormone-resistant, less differentiated and more aggressive, MDA-MB-468. In addition, subcellular localization of GLUT1 also was analysed in MDA-MB-468 grown as xenografts in nude athymic BALB/c male mice. GLUT1 protein expression was observed in MCF-7, MDA-MB-468 and HMEC (Fig. 5). In HMEC cells, GLUT1 showed a distribution pattern that suggested intracellular localization of the protein in the perinuclear region (Fig. 5A). Low levels of GLUT1 immunostaining were detected at the cellular membrane in HMEC cells; however, GLUT1 protein was not localized to areas of the cellular membranes that faced neighbouring cells
Consistent with the in vivo studies, both breast cancer cell lines (MCF-7 and MDA-MB-468) showed consistently higher levels of GLUT1 immunostaining at the portion of the cellular membranes that faced neighbouring cells compared with portions of the cellular membranes that did not
, G, I). No consistent differences in the level of expression of GLUT1 were observed between the MCF-7 and MDA-MB-468 breast cancer cell lines. Incubation of the in vitro specimens in the absence of the primary antibody provided the negative controls (Fig. 5B, E, H). Taken together, © 2008 The Authors Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 3 Preferential localization of GLUT1 to cellular membranes involved in cell-to-cell contact. (A) Immunodetection of GLUT1 using peroxidase-based immunohistochemistry. The highest intensity of GLUT1 immunostaining was observed in areas of cellular membranes involved in cell-to-cell contact (arrows). (B-E) Semi-quantitative analysis of the preferential cellular localization of GLUT1 analysed using immunofluorescence coupled to digital image analysis in 3 different samples of grade SBRII breast cancer. The highest intensity of immunostaining was observed in cellular membranes involved in cell-to-cell contact (B-C, E -arrows). However, low level of immunostaining was observed in portions of the cellular membrane that contacted stroma (B-D, E -arrow heads). CC, cancer cells; St, stroma. Images
these data confirmed the preferential subcellular localization of GLUT1 to areas of the cellular membranes that faced neighbouring cells in the breast cancer cell lines, MCF-7 and MDA-MB-468. Expression and subcellular localization of GLUT1 in canaliculilike structures was analysed in MDA-MB-468 cells grown as xenografts in nude athymic BALB/c male mice
arrows). At the cellular level, GLUT1 localized © 2008 The Authors Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 4 Ultrastructural analysis of the GLUT1 expression in grade SBRII breast cancer. (A) GLUT1 subcellular localization was analysed using immunohistochemistry coupled to transmission electron microscopy (TEM). Lower panels (B-D) represent enlarged areas of the upper figure (A). Ultrathin sections were incubated 2 hrs with gold-labelled anti-rabbit IgG secondary antibody. Gold particles, indicative of the presence of a GLUT1 molecule, localized preferentially to areas of the cellular membranes involved in cell-to-cell contact, which associated with 'canaliculi-like structures' (A, B, C, asterisks and arrows). Gold particles were not observed in areas of cellular membranes involved in cell-to-cell contact, which did not form 'canaliculi-like structures' (B, arrow heads). Consistently lower density of gold particles was observed at the apical portion of the cellular membranes (D, arrow). MV:
microvillus. Image A: ϫ12,000. Images B-C: 45,000. preferentially to the cellular membranes of the cancer cells (Fig. 6C, arrows) (Fig. 6D, arrows) . Ultrastructural analysis indicated that these tumours formed intercellular canaliculi-like structures that were limited by cellular junctions (Fig. 6E, arrows) . Ultrastructural immunocytochemistry analysis demonstrated that GLUT1 localized predominantly to the cellular membrane prolongations present in these canaliculi-like structures (Fig. 6F and inset) .
Discussion
Activation of GLUT gene expression for enhanced uptake and metabolism of glucose is a molecular feature of the malignant phenotype in a variety of cancers, which include breast cancer [2-7, 9, 10, 21, 23, 24, 26] [30, 31] . In accordance with previous studies [7, 10] The appearance of GLUT1-positive clones in non-small cell lung carcinoma (NSCLC) has been associated with a more aggressive biological behaviour in these tumours [21] . GLUT1 expression in the colorectal carcinomas at stage T1 and T2 has been correlated to depth of invasion and histological differentiation. Furthermore, GLUT1 expression was observed to be a late event during progression of Barrett's metaplasia (BM) to carcinoma [25] . In breast cancer, Younes et al. [10] 
Fig. 6 Immunodetection of GLUT1 in MDA-MB-468-derived xenograft tumours induced in nude athymic BALB/c male mice. (A) Routine Mayer's haematoxylin and eosin stain (H&E). Histological analysis indicated a characteristic pattern of cellular columns with active proliferation (asterisk), and areas of cell death due to apoptosis or necrosis (black arrows). (B) Detection of cell death using the TUNEL technique in MDA-MB-468-derived xenograft tumours (white arrow). (C) GLUT1 immunostaining in MDA-MB-468-derived xenograft tumours. At the cellular level, GLUT1 localized preferentially to the cellular membranes of cancer cells (arrows). (D) Toluidine blue stain showing 'canaliculi-like structures' (arrows). (E) Ultrastructural analysis (TEM) of the MDA-MB-468-derived xenograft tumours showing 'canaliculi-like structures' (*) limited by cellular junctions (arrows). (F) Ultrastructural immunohistochemistry (immuno-gold) demonstrated GLUT1 expression at the 'canaliculi-like structures' in MDA-MB-468-derived xenograft tumours.
Images A-C: ϫ250; D: ϫ250; E: ϫ600; F: ϫ6000; G: ϫ16,000; H: ϫ45,000. N: nucleus. [10] , and other tumour models [22, 32, 33] . An alternative explanation for these results could be the SBR grading system. Because histological grading for breast cancer was reported first in 1925 [34] , several different prognostic classifications have been introduced. The SBR grade evaluates ducto-glandular formation and nuclear pleomorphism, and currently is the most frequently used grading scheme [35] . However, SBR grading has been criticized because of its lack of reproducibility [36] , a disproportionally large group of patients are placed in grade SBRII, and SBRII and SBRIII are difficult to distinguish, particularly in the subgroup of patients that are node negative [35, 37, 38] [10] . Another group reported contradictory results in the same tumour model [39] . In addition, no correlation was found between GLUT1 expression and cellular proliferation in colorectal adenocarcinoma cell lines [40] . Although [41, 42] . In contrast, GLUT1 showed no preferential distribution in non-polarized cellular models, such as erythrocytes or astrocytes [43] .
Verhey et al. [44] focused on analysis of the differential trafficking and subcellular localization of the GLUT1 and GLUT4 isoforms using recombinant chimeric transporters in which reciprocal domains were exchanged between GLUT1 and GLUT4. The carboxy-terminal 30 amino acids was responsible for differential cellular targeting of the GLUT isoforms GLUT1 and GLUT4, which suggests a putative protein domain could modulate trafficking and subcellular distribution [44] . Similar results were obtained by Mitsumoto and Klip [45] [41, 42, 44, 45] 
in L6 muscle cells, which indicate that subcellular distribution of GLUTs is regulated during myogenesis. Even though it is accepted that subcellular distribution of GLUTs is highly regulated in normal tissues
